OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Unique Subset of CD4+CD25highFoxp3+ T Cells Secreting Interleukin-10 and Transforming Growth Factor-β1 Mediates Suppression in the Tumor Microenvironment
Laura Strauss, Christoph Bergmann, Mirosław J. Szczepański, et al.
Clinical Cancer Research (2007) Vol. 13, Iss. 15, pp. 4345-4354
Closed Access | Times Cited: 435

Showing 1-25 of 435 citing articles:

How regulatory T cells work
Dario A.A. Vignali, Lauren W. Collison, Creg J. Workman
Nature reviews. Immunology (2008) Vol. 8, Iss. 7, pp. 523-532
Open Access | Times Cited: 3104

The tumor microenvironment and its role in promoting tumor growth
Theresa L. Whiteside
Oncogene (2008) Vol. 27, Iss. 45, pp. 5904-5912
Open Access | Times Cited: 2198

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation
Qizhi Tang, Jeffrey A. Bluestone
Nature Immunology (2008) Vol. 9, Iss. 3, pp. 239-244
Open Access | Times Cited: 1007

T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Andrea Facciabene, Gregory T. Motz, George Coukos
Cancer Research (2012) Vol. 72, Iss. 9, pp. 2162-2171
Open Access | Times Cited: 742

Immunology and Immunotherapy of Head and Neck Cancer
Robert L. Ferris
Journal of Clinical Oncology (2015) Vol. 33, Iss. 29, pp. 3293-3304
Open Access | Times Cited: 610

PD-1–Expressing Tumor-Infiltrating T Cells Are a Favorable Prognostic Biomarker in HPV-Associated Head and Neck Cancer
Cécile Badoual, Stéphane Hans, Nathalie Merillon, et al.
Cancer Research (2012) Vol. 73, Iss. 1, pp. 128-138
Open Access | Times Cited: 593

Deciphering and Reversing Tumor Immune Suppression
Greg Motz, George Coukos
Immunity (2013) Vol. 39, Iss. 1, pp. 61-73
Open Access | Times Cited: 545

Tumor microenvironment participates in metastasis of pancreatic cancer
Bo Ren, Ming Cui, Gang Yang, et al.
Molecular Cancer (2018) Vol. 17, Iss. 1
Open Access | Times Cited: 494

Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
David G. DeNardo, Pauline Andreu, Lisa M. Coussens
Cancer and Metastasis Reviews (2010) Vol. 29, Iss. 2, pp. 309-316
Open Access | Times Cited: 485

Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg)
Marta Szajnik, Malgorzata Czystowska, Mirosław J. Szczepański, et al.
PLoS ONE (2010) Vol. 5, Iss. 7, pp. e11469-e11469
Open Access | Times Cited: 437

Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
Belal Chaudhary, Eyad Elkord
Vaccines (2016) Vol. 4, Iss. 3, pp. 28-28
Open Access | Times Cited: 435

The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature
Ronald J. deLeeuw, Sara E. Kost, Juzer Kakal, et al.
Clinical Cancer Research (2012) Vol. 18, Iss. 11, pp. 3022-3029
Open Access | Times Cited: 424

Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide, James S. Wilmott, Richard A. Scolyer, et al.
Clinical Cancer Research (2017) Vol. 24, Iss. 6, pp. 1260-1270
Open Access | Times Cited: 377

A Review on Graphene-Based Nanomaterials in Biomedical Applications and Risks in Environment and Health
Thabitha P. Dasari Shareena, Danielle McShan, Asok K. Dasmahapatra, et al.
Nano-Micro Letters (2018) Vol. 10, Iss. 3
Open Access | Times Cited: 352

Regulatory T cells in nonlymphoid tissues
Dalia Burzyn, Christophe Benoist, Diane Mathis
Nature Immunology (2013) Vol. 14, Iss. 10, pp. 1007-1013
Open Access | Times Cited: 322

LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites
Chiara Camisaschi, Chiara Casati, Francesca Rini, et al.
The Journal of Immunology (2010) Vol. 184, Iss. 11, pp. 6545-6551
Open Access | Times Cited: 321

The development and function of regulatory T cells
Creg J. Workman, Andrea L. Szymczak-Workman, Lauren W. Collison, et al.
Cellular and Molecular Life Sciences (2009) Vol. 66, Iss. 16, pp. 2603-2622
Open Access | Times Cited: 314

FOXP3 Expression and Overall Survival in Breast Cancer
Andrea Merlo, Patrizia Casalini, Maria Luisa Carcangiu, et al.
Journal of Clinical Oncology (2009) Vol. 27, Iss. 11, pp. 1746-1752
Closed Access | Times Cited: 296

Immune checkpoint inhibitors in cancer therapy: a focus on T‐regulatory cells
Varun Sasidharan Nair, Eyad Elkord
Immunology and Cell Biology (2017) Vol. 96, Iss. 1, pp. 21-33
Open Access | Times Cited: 267

What are regulatory T cells (Treg) regulating in cancer and why?
Theresa L. Whiteside
Seminars in Cancer Biology (2012) Vol. 22, Iss. 4, pp. 327-334
Open Access | Times Cited: 264

The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Seong Keun Kim, Sun Wook Cho
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 256

FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
Reem Saleh, Eyad Elkord
Cancer Letters (2020) Vol. 490, pp. 174-185
Open Access | Times Cited: 248

CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis
Hyun-Bae Jie, Patrick J. Schuler, Steve Lee, et al.
Cancer Research (2015) Vol. 75, Iss. 11, pp. 2200-2210
Open Access | Times Cited: 245

Differentiation and function of Foxp3+ effector regulatory T cells
Erika Cretney, Axel Kallies, Stephen L. Nutt
Trends in Immunology (2012) Vol. 34, Iss. 2, pp. 74-80
Closed Access | Times Cited: 237

Natural and Induced T Regulatory Cells in Cancer
Dennis O. Adeegbe, Hiroyoshi Nishikawa
Frontiers in Immunology (2013) Vol. 4
Open Access | Times Cited: 230

Page 1 - Next Page

Scroll to top